1) La descarga del recurso depende de la página de origen
2) Para poder descargar el recurso, es necesario ser usuario registrado en Universia


Opción 1: Descargar recurso

Detalles del recurso

Descripción

Components of the mitochondrial electron transport chain have recently gained much interest as potential therapeutic targets. Since mitochondria are essential for the supply of energy that is required for both angiogenic and tumourigenic activity, targeting the mitochondria represents a promising potential therapeutic approach for treating cancer. Here we investigate the established anti-angiogenesis drugs combretastatin A4, thalidomide, OGT 2115 and tranilast that we hypothesise are able to exert a direct anti-cancer effect in the absence of vasculature by targeting the mitochondria. Drug cytotoxicity was measured using the MTT assay. Mitochondrial function was measured in intact isolated mitochondria using polarography, fluorimetry and enzymatic assays to measure mitochondrial oxygen consumption, membrane potential and complex I–IV activities respectively. Combretastatin A4, OGT 2115 and tranilast were both shown to decrease mitochondrial oxygen consumption. OGT 2115 and tranilast decreased mitochondrial membrane potential and reduced complex I activity while combretastatin A4 and thalidomide did not. OGT 2115 inhibited mitochondrial complex II–III activity while combretastatin A4, thalidomide and tranilast did not. Combretastatin A4, thalidomide and OGT 2115 induced bi-phasic concentration-dependent increases and decreases in mitochondrial complex IV activity while tranilast had no evident effect. These data demonstrate that combretastatin A4, thalidomide, OGT 2115 and tranilast are all mitochondrial modulators. OGT 2115 and tranilast are both mitochondrial inhibitors capable of eliciting concentration-dependent reductions in cell viability by decreasing mitochondrial membrane potential and oxygen consumption.

Pertenece a

Faculty of Technology ePrints Service  

Autor(es)

Quayle, Lewis A. -  Pereira, Maria G. -  Scheper, Gerjan -  Wiltshire, Tammy -  Peake, Ria E. -  Hussain, Issam -  Rea, Carol A. -  Bates, Timothy E. - 

Id.: 70123671

Idioma: inglés  - 

Versión: 1.0

Estado: Final

Tipo:  application/pdf - 

Palabras claveB290 Pharmacology, Toxicology and Pharmacy not elsewhere classified - 

Tipo de recurso: Article  -  PeerReviewed  - 

Tipo de Interactividad: Expositivo

Nivel de Interactividad: muy bajo

Audiencia: Estudiante  -  Profesor  -  Autor  - 

Estructura: Atomic

Coste: no

Copyright: sí

: cc_by4

Formatos:  application/pdf - 

Requerimientos técnicos:  Browser: Any - 

Relación: [References] http://eprints.lincoln.ac.uk/28966/
[References] 10.18632/oncotarget.20858

Fecha de contribución: 06-oct-2017

Contacto:

Localización:
* Quayle, Lewis A. and Pereira, Maria G. and Scheper, Gerjan and Wiltshire, Tammy and Peake, Ria E. and Hussain, Issam and Rea, Carol A. and Bates, Timothy E. (2017) Anti-angiogenic drugs: direct anti-cancer agents with mitochondrial mechanisms of action. Oncotarget, 10 . ISSN 1949-2553

Otros recursos de la mismacolección

  1. Pumping in oxygen Coverage of so called Islamic State (IS), as with the reporting of the jihadi threat in the “war aga...
  2. Traitors or toadies? [The BBC: myth of a public service, by Mills, Tom (Verso, pp266, £16.99)] From 1934 until 1984 that bastion of journalist integrity, the national treasure that is the BBC, ha...
  3. Time for a cover-up The most boring headline imaginable according, supposedly, to Claud Cockburn, is: “Small earthquake ...
  4. Animal and human emotion: concepts and methodologies The human-dog relationship is particularly interesting for the study of emotions. The underlying con...
  5. Indigenous self-determination: the root of state resistance States have long expressed some resistance towards granting the right of self-determination to ident...

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.